WIXLIB

1-pres2021-20222020-20222021-presChair, ASPET, Teaching Institute symposium entitled: Practical Technologies forEffective Teaching at Experimental Biology, San Diego, CA, April 26, 2014ASPET, Division for Pharmacology Education, Executive Committee Representative,Graduate RecruitmentSubcommittee, Revision of Cardiovascular and Respiratory PharmacologyLearning Objectives for the American Medical School Pharmacology Chairs (AMSPC)Knowledge Objectives in Medical School Pharmacology (7th edition)Co-chair, ASPET, Teaching Institute symposium entitled: Training Students forCareers in Teaching at Experimental Biology, Boston, MA, March 28, 2015Secretary/Treasurer-Elect, Division of Pharmacology Education, ASPETWorking Group Member, Interprofessional Education/Collaborative Care Network ofthe Committee on Institutional Cooperation (CIC) for the Big Ten UniversitiesCo-chair, ASPET, Teaching Institute symposium entitled: Developing Mentees UsingIDPs at Experimental Biology, San Diego, CA, April 2, 2016Secretary/Treasurer, Division of Pharmacology Education, ASPETMembership Committee, American Interprofessional Health CollaborativeOrganizing Committee, National Directors of Graduate Studies (ASPET and APS)2017 meetingMember, ASPET, Nominating Committee (President, Treasurer, Councilors)Member, ASPET, Division of Pharmacology Education, Programming Committee for2018Division of Pharmacology Education, ASPET, Executive Committee (immediate pastsecretary/treasurer)Expert Panelist, Interprofessional Education Consortium (IPEC) for Leveraging theIPEC Competency Framework to Transform Health Profession Education.Chairperson, Intra-University Relations Committee, Communications ChairSelected as the Intra-university Relations Committee, “Shared Resources” LeadAppointed to the International Union of Pharmacology (IUPHAR) Core Concepts ofPharmacology Education Working GroupLOCAL EVENTS PLANNED:2015Event Planner, Office of Interprofessional Collaborative Education and Teamwork,PSU COM Inaugural Lecture and Workshop by Alan Dow, MD, entitled: Education forthe New Healthcare: Defining Interprofessional Competencies for GraduatingStudents, Hershey, PA, December 10, 2014.2016Event Planner, Office of Interprofessional Collaborative Education and Teamwork,PSU COM Lecture and Workshop by Jana Zaudke, MD, and Sarah Shrader, PharmD,entitled: Interprofessional Learning In Practice, Hershey, PA, June 23, 2016.2017Event Planner, Office of Interprofessional Collaborative Education and Teamwork,Combined Medicine-Pediatrics Grand Rounds with John Dent, MD, and Dana Palmer,RN entitled: Designed to succeed: The Power of Intentional InterprofessionalCollaboration to Improve Patient and Family Centered Care, Hershey PA, August, 29,2017 (CME/CNE).2017Event Planner, Office of Interprofessional Collaborative Education and Teamwork,Workshop by John Owen, EdD, Developing, Implementing & Assessing a ContinuingInterprofessional Education (CIPE) Program to Achieve Organizational Goals: Using6

C. difficile Infection Reduction As a An Example, Hershey, PA, August, 29, 2017(CME/CNE).2017Co-organizer, Getting Started: An Interprofessional Education/InterprofessionalPractice Workshop for Healthcare Educators and Providers, Hershey, PA, October 26and 27, 2017 (16 CNE credits)2018Event Planner, Office of Interprofessional Collaborative Education and Teamwork Twoworkshops by Mayumi Willgerodt, Ph.D., MPH/MS, RN and Jennifer Danielson,PharmD, MBA, CDE, entitled: Team Development in Interprofessional CollaborativePractices: Strategies and Lessons Learned (CNE) and Add-ons or Add-ins?Developing, Integrating, and Evaluating Interprofessional Learning OpportunitiesAcross the Learning Continuum (CNE), Hershey, PA, November 29, 2018GRANT SUPPORT:CURRENT:Health Resources and Services Administration 1 TOBHP30010-01-00. “Primary Care Trainingand Enhancement Program” (Leong). Role: Co-Investigator, (20% FTE over 5 years) 07/01/1606/30/21 ( 2,388,991); currently in a one year no-cost extension.COMPLETEDChildren’s Miracle Network. “Contribution of Perinatal Factors to Development of Food Allergies,”Role: Primary Investigator, 07/01/07-06/30/11 ( 15,705).Association of Faculty and Friends. “Institutional Subscription to Natural Medicine ComprehensiveDatabase and Development of Electronic Physician Training Modules”. Role: Primary Investigator,07/01/08-06/30/09( 3000).Woodward Endowment for Medical Sciences Education. “Educational Initiatives to EnhanceHerbal/Natural Product Knowledge of Students and Clinicians,” Role: Primary Investigator, 07/01/0806/30/12 ( 18,394).National Institute of Justice. “Use of Calmatives as Non-lethal Weapons” (with PSU AppliedResearch Labs). Role: Co-Investigator, 10/21/08-12/31/09 ( 100,795).Association of Faculty and Friends. “Assessing the Impact of an Herbal/Natural MedicineEvidence-Based Tool”. Role: Primary Investigator, 7/1/09-6/30/14 ( 3000).Association of Faculty and Friends. “Efficacy of a Lactobacillus-Bifidobacteria Combination toPrevent Antibiotic-Associated Side Effects: A Double-Blind, Placebo-Controlled Feasability Study”.Role: Primary Investigator, 7/1/10-06/30/14 ( 3000).Woodward Endowment for Medical Sciences Education. “Development of MedicationReconciliation Learning Activities and Implementation in a Medical Home Curriculum”. Role: PrimaryInvestigator, 7/1/10-6/30/14 ( 25,000).7

Health Resources and Services Administration. “Building Workforce Capacity: Patient-CenteredMedical Home” (Leong). Role: Co-Investigator, (average 15% FTE across 5 years) 9/1/10-8/30/15( 1.463 million).Ganeden. “Further Evaluation of the Probiotic Bacillus coagulans GBI-30 in a Murine Model ofClostridium difficile-Induced Colitis”. (Fitzpatrick) Role: Co- Investigator, 04/01/11-09/30/11.Association of Faculty and Friends. “Assessing Efficacy of Probiotics for Reducing Incidence ofAntibiotic-Associated Diarrhea and Vaginal Yeast in Primary Care”. Role: Primary Investigator,7/1/11-6/30/14 ( 3000).Association of Faculty and Friends. “Analyzing Data Generated by the ‘Efficacy of a LactobacillusBifidobacteria Combination to Prevent Antibiotic Associated Side Effects’ Trial”. Role: PrimaryInvestigator, 7/1/11-6/30/14 ( 3000).Association of Faculty and Friends. “Assessing Impact of Pharmacology Educational Innovationson Learners’ Outcomes”. Role: Primary Investigator, 7/1/11-6/30/14 ( 3000).Woodward Endowment Travel Award. Presented “It’s a Beautiful Day in the Medical HomeNeighborhood” Faculty Development Workshop at Society of Teachers of Family MedicineConference for Medical Student Education. Role: Medication Reconciliation Instructor, awardedSeptember 1, 2011 ( 2000).Woodward Endowment for Medical Sciences Education.“Evaluating Outcomes of the BiomedicalSciences Graduate Program and Predicting Successes in Graduate School”. Role: PrimaryInvestigator, 4/1/12-9/30/13 ( 25,000).ASPET Travel Award for Pharmacology Educators.4/1/2012-06/30/2012 ( 1,000).Association of Faculty and Friends. “Lab Educational Exercises in the PULSE Program”. Role:Primary Investigator, 7/1/12-12/31/13 ( 2995).Woodward Endowment Travel Award. “Implementation of a Longitudinal Curriculum on the PCMH:Student and Patient Outcomes”. Role: Seminar Instructor, Society of Teachers of Family MedicineMedical Education Conference, San Antonio, TX. Awarded November 30, 2012 ( 2000).Cardinal Health Foundation. Funds to Participate in an Institute for Health Improvement (IHI)Program. Role: Primary Investigator, 7/1/13-6/30/14 ( 2,130).Woodward Endowment Travel Award. “Moving Icebergs: Practical Solutions for SuccessfullyImplementing Interprofessional Education”. Role: Workshop presenter, American Association ofMedical Colleges, Chicago, IL. Awarded September 1, 2014 ( 2000).Health Resources and Services Administration 5 D09HP25919-02-00. “Embedding IPECompetencies into a Nurse Practitioner Program for Underserved Communities in Pennsylvania”(McDowell). Role: Co-Investigator, (10% FTE) 10/1/2014-6/30/16 ( 344,566).Public Health Sciences Community Service Start Up Grant. “Interdisciplinary Service Learning:Hershey Plaza”. Role: Faculty Advisor for Student Interprofessional Community Service Group, (0%FTE) 1/1/16-12/31/16 ( 3000).Woodward Endowment for Medical Sciences Education. “Interprofessional Pharmacology ClinicalReasoning Curriculum”. (0% FTE) 3/1/14-12/31/16. ( 24,627).8

Josiah Macy Faculty Scholar. “Interprofessional Medication Safety Education”. (65% FTE)9/1/2013-8/31/2018. ( 216,291).Health Resources and Services Administration 1 TOBHP30010-01-00. “Opioid UseDisorder/Medication Assisted Treatment Supplemental Funding Award” (Leong) 07/01/17-06/30/18( 79,839).NIH 1 R13 GM 108284 – 01. “National Pharmacology Directors of Graduate Programs Meeting”.(Barnett and Karpa). Role: Co-primary investigator, (0% FTE) 7/1/14-6/30/19 ( 60,845).Health Resources and Services Administation TOBHP30010. “HRSA PCTE Addiction MedicineSupplement” (Leong/Gonzalo) Role: Co-investigator, awarded 06-27-18 ( 100,000)BIBLIOGRAPHYRepresenting 3 books, 1200 brief articles, clinical updates, monographs, and peer-reviewedmanuscriptsBOOKS AUTHORED1.Karpa KD. Bacteria for Breakfast: Probiotics for Good Health, Trafford, Victoria, BritishColumbia, Canada, 2003, 319 pp., ISBN- 141200925-1.2.Kester M, Vrana K, Quraishi S, Karpa K. Elsevier’s Integrated Pharmacology, Elsevier Ltd.,2007, 235 pp., ISBN-13 978-0-323-03408-1. USMLE Step 1 review textbook. [also translatedinto Portuguese and Japanese and licensed for release in Turkish; received the British MedicalAssociation’s “Highly Commended” designation for a basic and clinical science textbook in2008].3.Kester M, Vrana K, Karpa K. Elsevier’s Integrated Review Pharmacology, 2nd edition, ElsevierLtd., 2012, 245 pp., ISBN-978-0-323-07445-2.BOOK CHAPTERS AUTHORED4.Fitzpatrick L and Karpa KD. Probiotic Treatment of Colitis in Animal Models and People. InWatson RR and Preedy VR, eds. Bioactive Foods in Promoting Health: Probiotics andPrebiotics, Oxford: Academic Press, 2010, pp 571-587.5.Karpa KD. Calcium Channel Blockers. Brody’s Human Pharmacology, 6th edition. Elsevier,2018.6.Herrman F, Kocis PT, Karpa KD, and Vrana KE. Antithrombotic Medications. Brody’sHuman Pharmacology, 6th edition. Elsevier, 2018.7.Karpa K. Interprofessional Education (IPE). In Huggett K and Jeffries W (Eds) AnIntroduction to Medical Teaching, 3rd edition. Springer. 2022PEER-REVIEWED MANUSCRIPTS9

7.Karpa KD, Lidow MS, Levenson R, Bergson C. N-linked glycosylation is required for plasmamembrane localization of D5, but not D1, dopamine receptors in transfected mammalian cells.Mol Pharmacol. 1999;56:1071-78.8.Karpa KD, Lin R, Kabbani N, Levenson R. The dopamine D3 receptor interacts with itselfand the truncated D3 splice variant, D3nf: D3-D3nf interaction causes mislocalization of D3receptors. Mol Pharmacol. 2000;58:677-83.9.Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. Dopamine D2 and D3 receptorsare linked to the actin cytoskeleton via interaction with filamin A. Proc Natl Acad Sci USA.2001;98:5258-63.10.Karpa, KD, Cavanaugh JE, Lakoski JM. Duloxetine pharmacology: profile of a dualmonoamine modulator. CNS Drug Rev. 2002;8:361-76.11.Barrette EP, Basch E, Boon H, Ebert B, Dowhower Karpa K, Kerbel B, Szapary P,Thompson-Hoffman T, Tsourounis C, Ulbricht C. Lycopene efficacy as a preventative therapyfor cancer. J Cancer Integrative Med. 2003;1:23-31.12.Basile M, Lin R, Kabbani N, Karpa K, Kilimann M, Simpson I, Kester M. Paralemmin interactswith D3 dopamine receptors: implications for membrane localization and cAMP signaling.Arch Biochem Biophys. 2006;446:60-8.13.Karpa KD. Pharmacist critique was ill-informed. Ann Pharmacother. 2006;40(6):1441-44.14.Karpa KD. Probiotics for C. difficile diarrhea: putting it into perspective. Ann Pharmacother.2007;41:1284-87.15.Ulbricht C, Basch E, Boon H, Karpa K, Gianutsos G, Nummy K, Seamon E, Smith M, SollarsD, Tanguay-Colucci S, Varghese M, Wiessner W, Woods J. An evidence-based systematicreview of passion flower (Passiflora incarnata L.) by the Natural Standard ResearchCollaboration J Dietary Supplements 2008;5(3):310-340.16.Imhoff A, Karpa K. Is there a future for probiotics in Clostridium difficile-associated diseaseand treatment of recurrent episodes? Nutr Clin Pract. 2009;24(1):15-32. [invited review].17.Ritchie B, Pingatore B, Alexander D, Karpa K. Pharmacists' experience and knowledge ofprobiotic supplements. Int J Probiotics Prebiotics. 2009;4(1):23-32.18.Graul T, Cain AM, Karpa KD. Lactobacillus and bifidobacteria combinations: a strategy toreduce hospital-acquired Clostridium difficile diarrhea incidence and mortality. MedHypotheses. 2009;74:194-98.19.Murray WB, Wood J, Schwab M, Fritz M, and Karpa KD. Human patient simulation inpharmacology graduate education: bridging the bench-to-bedside gap. Mol Interv.2010;10(3):127-132.20Cain AM, Karpa KD. Clinical utility of probiotics in inflammatory bowel disease. Altern TherHealth Med.2011;17(1):72-79.21.Boehmer S, Karpa KD. Evaluating the utility of a natural medicine clinical decision tool at anacademic medical center. BMC Health Services and 10

22.Fitzpatrick D, Small JS, Greene WH, Karpa KD, Keller D. Bacillus coagulans GBI-30 (BC30)improves indices of Clostridium difficile-induced colitis in mice. Gut Pathogens. 2011;3:16.doi:10.1186/1757-4749-3-16.23.Karpa KD, Boehmer S. Examining utilization of a natural medicine web-based tool amongnon–primary care physicians, academic faculty, and nurses at one institution. AnnPharmacother. 2012;46:513-520.24.Karpa, KD. Development and implementation of an herbal and natural product elective inundergraduate medical education. BMC Compl Alt Med. 2012;12:57. doi:10.1186/1472-688212-5725.Berdine HJ, Dougherty T, Karpa K, Kozminski M, Leon N, Osborne M, Peterson A, WilleyVJ. The pharmacists’ role in the patient-centered medical home (PCMH). Ann Pharmacother.2012;46:723-750. doi:10.1345/aph.1R18926.Karpa KD and Abendroth CS. How we conduct ongoing programmatic evaluation of ourmedical education curriculum. Medical Teach.2012;34:783-786.27.Karpa KD, Paul I, Leckie JA, Shung S, Salli N, Vrana KE, Mauger D, Fausnight T, Poger J. Aretrospective chart review to identify perinatal factors associated with food allergies. Nutr J.2012;11:87. doi:10.1186/1475-2891-11-8728.Fitzpatrick LR, Small JS, Greene WH, Karpa KD, Farmer S, Keller D. Bacillus coagulansGBI-30, 6086 limits the recurrence of Clostridium difficile-induced colitis following vancomycinwithdrawal in mice. Gut Pathogens. 2012;4:13. doi:10.1186/1757-4749-4-1329.Karpa K, Haidet P. Medication Reconciliation Clinical Case - Demonstration. MedEdPORTAL;2012. Available from:www.mededportal.org/publication/926530.Karpa K. Medication Reconciliation Simulation. MedEdPORTAL; 2012. Available from:www.mededportal.org/publication/9275.31.Karpa KD, Vrana KE. Creating a virtual pharmacology curriculum in a problem-based learningenvironment: one medical school’s experience. Acad Med. 2013;88(2):198-205.32.Shelkey J, Huang C, Karpa KD, Singh H, Silvis M. Case Report: Pelvic congestion syndromeas an unusual etiology for chronic hip pain in two active, middle-age women. SportsHealth.2014;6(2):145-148.doi: 10.1177/1941738113481940.33.Patel J. Curry WJ, Graybill MA, Bernard S, McDermott AS, Karpa K. Randomized study ofprobiotics in primary care. J Pharm Health Serv Research. 2014; 5(3):187-190.34.Chin-Lee B, Curry WJ, Fetterman J, Graybill MA, Karpa, K. Patient experience and use ofprobiotics in community-based healthcare settings. Patient Preferences and Adherence.2014;8:1513-1520.35.Karpa K, Whaley S. Teaching first order pharmacokinetics with team-based learning.MedEdPORTAL Publications; 2014. Available from: https://www.mededportal.org/publication/9963 http://dx.doi.org/10.15766/mep 2374-8265.996336.Karpa K, Messmer J, Jiang E, Leong S. Demonstrating team-based care in primary careenvironments via video modules and discussion. MedEdPORTAL Publications; 2015.11

Available from: //dx.doi.org/10.15766/mep 2374-8265.1011637.Karpa K, Whaley S, Moore P. Small group activity to apply zero order pharmacokineticprinciples. MedEdPORTAL Publications; 2015. Available http://dx.doi.org/10.15766/mep 23748265.1017138.Karpa K, Vakharia K, Caruso C, Vechery C, Sipple L, Wang A. Medical student servicelearning program teaches secondary students about career opportunities in health andmedical fields. Adv Physio Edu. 2015; 39:315-319.39.Felix TM, Karpa KD, Lewis PR. Adverse effects of common drugs: dietary supplements. FPEssent. 2015;436:31-40 (Invited Review; CME).40.Lewis PR, Karpa KD, Felix TM. Adverse effects of common drugs: adults. FP Essent.2015;436:23-30 (Invited Review; CME).41.Karpa KD, Felix TM, Lewis PR. Adverse effects of common drugs: children and adolescents.FP Essent. 2015;436;17-22 (Invited Review; CME).42.Karpa KD, Lewis PR, Felix TM. Adverse effects of common drugs: general concepts. FPEssent. 2015;436:11-6 (Invited Review; CME).43.Dow A, Reising D, Peyre S, Zomorodi M, Hanyok L, van Schaik S, Karpa K, Hasnain M, DayL, Beard K, Willgerodt M, James T, Julion W, Madigosky W, Thibault G. Is it time for aninterprofessional professional society? J Interprof Edu Pract. 2015;1(3-4):79-82.44.Karpa K, Grine K. A covert standardized patient with medication-induced QT prolongation.MedEdPORTAL Publications; 2015. Available from:https://www.mededportal.org/publication/10312 http://dx.doi.org/10.15766/mep 23748265.1031245.Karpa KD, Hom LL, Huffman PM, Lehman EB, Chinchilli VM, Haidet P, Leong SL.Medication safety curriculum: enhancing skills and changing behaviors. BMC Med Edu.2015;15:234.46.McFalls AJ, Barnett JV, Karpa KD. 2015 meeting of the national directors of graduate studiesin pharmacology and physiology. Adv Phys Edu. 2016;40(1):134-141.47.Karpa K, Stollar K. Medication op

2021 Advisory Board Member, Millersville University, Social Work Program 2022 Accreditation Support Faculty, Elizabethtown College, Nursing Program PROFESSIONAL MEMBERSHIPS: 1991-pres American Pharmacist Association 1991-2002& Pennsylvania Pharmacists Association 2011-pres 1997-2000 Society for Neuroscience